NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China.
J Cell Physiol. 2022 Jul;237(7):2796-2807. doi: 10.1002/jcp.30760. Epub 2022 Apr 29.
CD38 is a multifunctional receptor and enzyme present on the surface of B lymphocytes, which can induce B lymphocytes proliferation and apoptosis by crosslinking related cytokines to affect the function of B cells, thus affecting immune regulation in humans and promoting tumorigenesis. The level of CD38 expression in B cells has become an important factor in the clinical diagnosis, treatment, and prognosis of malignant tumors and other related diseases. Therefore, studying the relationship between CD38 expression on the surface of B cells and the occurrence of the disease is of great significance for elucidating its association with disease pathogenesis and the clinical targeted therapy. In this paper, we review the effects of CD38 on B-cell activation, proliferation, and differentiation, and elaborate the functional role and mechanism of CD38 expression on B cells. We also summarize the relationship between the level of CD38 expression on the surface of B cells and the diagnosis, treatment, and prognosis of various diseases, as well as the potential use of targeted CD38 treatment for related diseases. This will provide an important theoretical basis for the scientific research and clinical diagnosis and treatment of B-cell-related diseases.
CD38 是 B 淋巴细胞表面的一种多功能受体和酶,通过交联相关细胞因子诱导 B 淋巴细胞增殖和凋亡,影响 B 细胞的功能,从而影响人类的免疫调节并促进肿瘤发生。B 细胞表面 CD38 的表达水平已成为恶性肿瘤等相关疾病临床诊断、治疗和预后的重要因素。因此,研究 B 细胞表面 CD38 的表达与疾病发生的关系,对于阐明其与疾病发病机制的关系以及临床靶向治疗具有重要意义。本文综述了 CD38 对 B 细胞激活、增殖和分化的影响,阐述了 CD38 在 B 细胞上表达的功能作用及其机制,总结了 B 细胞表面 CD38 表达水平与各种疾病的诊断、治疗和预后的关系,以及靶向 CD38 治疗相关疾病的潜在用途。这将为 B 细胞相关疾病的科学研究和临床诊断治疗提供重要的理论依据。